Chemoinformaics analysis of trans-Eudesma-4(15),7-dien-12-ol
| Molecular Weight | 220.356 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -3.679 | nHRing | 0 |
| Solubility: LogP | 3.755 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.704 |
| Synth | 4.413 |
| Natural Product Likeliness | 3.099 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.325 |
| MDCK | 0.0000144 |
| BBB | 0.987 |
| PPB | 0.814286 |
| VDSS | 1.306 |
| FU | 0.180055 |
| CYP1A2-inh | 0.176 |
| CYP1A2-sub | 0.551 |
| CYP2c19-inh | 0.061 |
| CYP2c19-sub | 0.786 |
| CYP2c9-inh | 0.063 |
| CYP2c9-sub | 0.235 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.72 |
| CYP3a4-inh | 0.231 |
| CYP3a4-sub | 0.327 |
| CL | 11.695 |
| T12 | 0.155 |
| hERG | 0.003 |
| Ames | 0.028 |
| ROA | 0.15 |
| SkinSen | 0.037 |
| Carcinogencity | 0.922 |
| EI | 0.102 |
| Respiratory | 0.291 |
| NR-Aromatase | 0.048 |
| Antiviral | Yes |
| Prediction | 0.910931 |